IRTC News and Press, iRhythm Technologies Inc. From 05/24/21

iRhythm Technologies (IRTC) has received FDA’s 510K clearances for a new design of its flagship Zio monitor and its updated artificial intelligence ((AI)) capabilities.“iRhythm’s new Zio monitor and enhanced AI further illustrate our commitment to raising the st...

SAN FRANCISCO, May 24, 2021 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced two new 510K clearances – one for a new and improved design of its flagship monitor an...

BTCY continues to win new business at a rapid pace, with current quarterly revenue likely to be double revenue reported just two quarters ago, well ahead of management’s past guidance. Reduced reimbursement rates for extended holter have no impact on BTCY, unlike the negative i...

iRhythm Technologies, Inc. (IRTC) Q1 2021 Earnings Conference Call May 06, 2021, 04:30 PM ET Company Participants Leigh Salvo - Head of IR Michael Coyle - CEO Douglas Devine - CFO Daniel Wilson - EVP, Strategy, CD & IR Conference Call Participants Robbie Marcus - JPMorgan Cecilia Furlong ...

Image source: The Motley Fool. iRhythm Technologies, Inc. (NASDAQ: IRTC) Q1 2021 Earnings Call May 6, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: iRhythm Technologies, Inc. (IRTC) Q1 2021 Earnings Call Transcrip...

iRhythm Technologies (IRTC): Q1 GAAP EPS of -$0.95 misses by $0.10.Revenue of $74.31M (+16.9% Y/Y) beats by $3.99M.Press Release For further details see: iRhythm Technologies EPS misses by $0.10, beats on revenue

SAN FRANCISCO, May 06, 2021 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended March 31, 2021. First Quarter 2021 Finan...

iRhythm (IRTC) rose 5.3% on speculation that the company could potentially see activist interest after its shares have plunged 69% this year before today on lower reimbursement rates for its heart monitoring device.The speculation comes as traders appear to be circulating an Insightia re...

ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Strategy outperformed through a rotation out of growt...

ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. An accelerating rotation into value stocks in the small c...